ASIC approves C3 name change
By Dylan Bushell-Embling
Tuesday, 17 June, 2008
Tuesday, 17 June, 2008
The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.
The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.
Related News
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
Mediterranean-style diet benefits maternal and infant health
Two studies have found that a Mediterranean-style diet benefits maternal health during pregnancy...
